Ahles TA - Search Results

1

Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.

Van Dyk K, Ahn J, Zhou X, Zhai W, Ahles TA, Bethea TN, Carroll JE, Cohen HJ, Dilawari AA, Graham D, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher KE, Saykin AJ, Small BJ, Mandelblatt JS, Root JC. Van Dyk K, et al. Among authors: ahles ta. J Geriatr Oncol. 2022 Nov;13(8):1132-1140. doi: 10.1016/j.jgo.2022.08.005. Epub 2022 Aug 24. J Geriatr Oncol. 2022. PMID: 36030173 Free PMC article.

2

Cognitive effects of standard-dose chemotherapy in patients with cancer.

Ahles TA, Saykin A. Ahles TA, et al. Cancer Invest. 2001;19(8):812-20. doi: 10.1081/cnv-100107743. Cancer Invest. 2001. PMID: 11768035 Review.

3

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM. Ahles TA, et al. J Clin Oncol. 2002 Jan 15;20(2):485-93. doi: 10.1200/JCO.2002.20.2.485. J Clin Oncol. 2002. PMID: 11786578

4

Breast cancer chemotherapy-related cognitive dysfunction.

Ahles TA, Saykin AJ. Ahles TA, et al. Clin Breast Cancer. 2002 Dec;3 Suppl 3:S84-90. doi: 10.3816/cbc.2002.s.018. Clin Breast Cancer. 2002. PMID: 12533268 Review.

5

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.

Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA. Ahles TA, et al. Psychooncology. 2003 Sep;12(6):612-9. doi: 10.1002/pon.742. Psychooncology. 2003. PMID: 12923801

6

Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.

Saykin AJ, Ahles TA, McDonald BC. Saykin AJ, et al. Among authors: ahles ta. Semin Clin Neuropsychiatry. 2003 Oct;8(4):201-16. Semin Clin Neuropsychiatry. 2003. PMID: 14613048 Review.

7

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.

McAllister TW, Ahles TA, Saykin AJ, Ferguson RJ, McDonald BC, Lewis LD, Flashman LA, Rhodes CH. McAllister TW, et al. Among authors: ahles ta. Curr Psychiatry Rep. 2004 Oct;6(5):364-71. doi: 10.1007/s11920-004-0023-y. Curr Psychiatry Rep. 2004. PMID: 15355759 Review.

8

Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy.

Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Titus-Ernstoff L, Skalla K, Bakitas M, Silberfarb PM. Ahles TA, et al. J Clin Oncol. 2005 Jul 1;23(19):4399-405. doi: 10.1200/JCO.2005.03.343. J Clin Oncol. 2005. PMID: 15994149 Free PMC article.

9

Cognitive-behavioral management of chemotherapy-related cognitive change.

Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Mott LA. Ferguson RJ, et al. Among authors: ahles ta. Psychooncology. 2007 Aug;16(8):772-7. doi: 10.1002/pon.1133. Psychooncology. 2007. PMID: 17152119 Free PMC article.

10

Candidate mechanisms for chemotherapy-induced cognitive changes.

Ahles TA, Saykin AJ. Ahles TA, et al. Nat Rev Cancer. 2007 Mar;7(3):192-201. doi: 10.1038/nrc2073. Nat Rev Cancer. 2007. PMID: 17318212 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page